Orexigen Therapeutics, Inc. 4
4 · Orexigen Therapeutics, Inc. · Filed Jul 14, 2016
Insider Transaction Report
Form 4
Endicott David J.
Director
Transactions
- Award
Stock Option
2016-07-12+15,000→ 15,000 totalExercise: $4.02Exp: 2026-07-11→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]The shares of stock subject to the option (rounded down to the next whole number of shares) shall vest in equal monthly installments over 12 months following 07/08/2016, subject to the Director's continuing service on the Board through each such date; provided, that if a Change in Control (as defined in the Plan) occurs, such option, to the extent unvested, shall become fully vested immediately prior to such Change in Control, subject to the Director's continuing service on the Board, as set forth in the applicable stock option grant notice and stock option agreement for such Director.
- [F2]Not Applicable